Literature DB >> 25078301

Epitope mapping of the 2009 pandemic and the A/Brisbane/59/2007 seasonal (H1N1) influenza virus haemagglutinins using mAbs and escape mutants.

Miguel Retamal1, Yacine Abed1, Jacques Corbeil1, Guy Boivin1.   

Abstract

mAbs constitute an important biological tool for influenza virus haemagglutinin (HA) epitope mapping through the generation of escape mutants, which could provide insights into immune evasion mechanisms and may benefit the future development of vaccines. Several influenza A (H1N1) pandemic 2009 (pdm09) HA escape mutants have been recently described. However, the HA antigenic sites of the previous seasonal A/Brisbane/59/2007 (H1N1) (Bris07) virus remain poorly documented. Here, we produced mAbs against pdm09 and Bris07 HA proteins expressed in human HEK293 cells. Escape mutants were generated using mAbs that exhibited HA inhibition and neutralizing activities. The resulting epitope mapping of the pdm09 HA protein revealed 11 escape mutations including three that were previously described (G172E, N173D and K256E) and eight novel ones (T89R, F128L, G157E, K180E, A212E, R269K, N311T and G478E). Among the six HA mutations that were part of predicted antigenic sites (Ca1, Ca2, Cb, Sa or Sb), three (G172E, N173D and K180E) were within the Sa site. Eight escape mutations (H54N, N55D, N55K, L60H, N203D, A231T, V314I and K464E) were obtained for Bris07 HA, and all but one (N203D, Sb site) were outside the predicted antigenic sites. Our results suggest that the Sa antigenic site is immunodominant in pdm09 HA, whereas the N203D mutation (Sb site), present in three different Bris07 escape mutants, appears as the immunodominant epitope in that strain. The fact that some mutations were not part of predicted antigenic sites reinforces the necessity of further characterizing the HA of additional H1N1 strains.
© 2014 The Authors.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25078301     DOI: 10.1099/vir.0.067819-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus.

Authors:  Jason R Wilson; Zhu Guo; Wen-Pin Tzeng; Rebecca J Garten; Xu Xiyan; Elisabeth G Blanchard; Kristy Blanchfield; James Stevens; Jacqueline M Katz; Ian A York
Journal:  Virology       Date:  2015-08-27       Impact factor: 3.616

2.  Association between Haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015.

Authors:  Sophia Ng; Saira Saborio; Guillermina Kuan; Lionel Gresh; Nery Sanchez; Sergio Ojeda; Eva Harris; Angel Balmaseda; Aubree Gordon
Journal:  Vaccine       Date:  2017-10-03       Impact factor: 3.641

3.  Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance.

Authors:  Sean T H Liu; Mohammad Amin Behzadi; Weina Sun; Alec W Freyn; Wen-Chun Liu; Felix Broecker; Randy A Albrecht; Nicole M Bouvier; Viviana Simon; Raffael Nachbagauer; Florian Krammer; Peter Palese
Journal:  J Clin Invest       Date:  2018-10-08       Impact factor: 14.808

4.  Influenza gain-of-function experiments: their role in vaccine virus recommendation and pandemic preparedness.

Authors:  S Schultz-Cherry; R J Webby; R G Webster; A Kelso; I G Barr; J W McCauley; R S Daniels; D Wang; Y Shu; E Nobusawa; S Itamura; M Tashiro; Y Harada; S Watanabe; T Odagiri; Z Ye; G Grohmann; R Harvey; O Engelhardt; D Smith; K Hamilton; F Claes; G Dauphin
Journal:  mBio       Date:  2014-12-12       Impact factor: 7.867

5.  Greater Breadth of Vaccine-Induced Immunity in Females than Males Is Mediated by Increased Antibody Diversity in Germinal Center B Cells.

Authors:  Rebecca L Ursin; Santosh Dhakal; Hsuan Liu; Sahana Jayaraman; Han-Sol Park; Harrison R Powell; Morgan L Sherer; Kirsten E Littlefield; Ashley L Fink; Zexu Ma; Alice L Mueller; Allison P Chen; Kumba Seddu; Yishak A Woldetsadik; Patricia J Gearhart; H Benjamin Larman; Robert W Maul; Andrew Pekosz; Sabra L Klein
Journal:  mBio       Date:  2022-07-20       Impact factor: 7.786

6.  Cross-protection against European swine influenza viruses in the context of infection immunity against the 2009 pandemic H1N1 virus: studies in the pig model of influenza.

Authors:  Yu Qiu; Karl De Hert; Kristien Van Reeth
Journal:  Vet Res       Date:  2015-09-24       Impact factor: 3.683

7.  Antigenic mapping of an H9N2 avian influenza virus reveals two discrete antigenic sites and a novel mechanism of immune escape.

Authors:  Thomas Peacock; Kolli Reddy; Joe James; Beata Adamiak; Wendy Barclay; Holly Shelton; Munir Iqbal
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

8.  Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system.

Authors:  Urmi Patel; Aaron Gingerich; Lauren Widman; Demba Sarr; Ralph A Tripp; Balázs Rada
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

9.  Genetic Analysis of Influenza A/H1N1pdm Strains Isolated in Bangladesh in Early 2020.

Authors:  Abu Hasan; Tadahiro Sasaki; Juthamas Phadungsombat; Ritsuko Koketsu; Rummana Rahim; Nikhat Ara; Suma Mita Biswas; Riku Yonezawa; Emi E Nakayama; Mizanur Rahman; Tatsuo Shioda
Journal:  Trop Med Infect Dis       Date:  2022-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.